Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

J Neuroimmunol. 2005 Dec;169(1-2):144-52. doi: 10.1016/j.jneuroim.2005.07.012. Epub 2005 Sep 22.

Abstract

Background: Increased expression of monocyte chemoattractant protein type 1 (MCP-1) is associated with HIV CNS disease. This study evaluated the temporal relationships between MCP-1 expression and HIV replication in the CNS.

Methods: MCP-1 and HIV viral load (VL) were measured in serially obtained samples of plasma and cerebrospinal fluid (CSF) in subjects either interrupting (TI) or starting (TS) antiretroviral therapy.

Results: Following TI, plasma VL rebounded first, followed by increases in CSF MCP-1, which immediately preceded or coincided with a rebound of CSF VL.

Conclusion: The close temporal relationship of the increase of MCP-1 and CSF VL suggests that they are co-regulated, or that one is a stimulus for the other.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Chemokine CCL2 / blood*
  • Chemokine CCL2 / cerebrospinal fluid*
  • Cognition Disorders / etiology
  • Cognition Disorders / virology
  • Female
  • HIV Infections / blood*
  • HIV Infections / cerebrospinal fluid*
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral / blood
  • RNA, Viral / cerebrospinal fluid
  • Time Factors
  • Viral Load / methods

Substances

  • Anti-Retroviral Agents
  • Chemokine CCL2
  • RNA, Viral